Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKesson
Chubb
Harvard Business School
Cerilliant
Accenture
Fish and Richardson
Cantor Fitzgerald
Federal Trade Commission

Generated: October 22, 2018

DrugPatentWatch Database Preview

Dr Reddys La Company Profile

« Back to Dashboard

What is the competitive landscape for DR REDDYS LA, and what generic alternatives to DR REDDYS LA drugs are available?

DR REDDYS LA has one hundred and seventy-eight approved drugs.

There are five US patents protecting DR REDDYS LA drugs. There are eleven tentative approvals on DR REDDYS LA drugs.

Summary for Dr Reddys La
US Patents:5
Tradenames:137
Ingredients:122
NDAs:178

Drugs and US Patents for Dr Reddys La

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Inc AUGMENTIN '125' amoxicillin; clavulanate potassium FOR SUSPENSION;ORAL 050575-001 Aug 6, 1984 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys Labs Ltd OMEPRAZOLE omeprazole CAPSULE, DELAYED REL PELLETS;ORAL 075576-001 Jan 21, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys Labs Ltd CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET;ORAL 078343-004 Jan 15, 2008 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys Labs Ltd ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 091650-002 Jul 17, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys Labs Ltd CETIRIZINE HYDROCHLORIDE HIVES cetirizine hydrochloride TABLET;ORAL 078343-002 Jan 15, 2008 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Dr Reddys La

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-004 Nov 12, 1999 4,597,961 ➤ Try a Free Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-006 Nov 12, 1999 4,597,961 ➤ Try a Free Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 5,016,652 ➤ Try a Free Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-004 Nov 12, 1999 5,834,011 ➤ Try a Free Trial
Dr Reddys Labs Sa HABITROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020076-005 Nov 12, 1999 5,834,011 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for DR REDDYS LA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Tablets 1000 mg/62.5 mg ➤ Subscribe 2009-01-21
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03

Supplementary Protection Certificates for Dr Reddys La Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
90035-0 98910359 Sweden ➤ Try a Free Trial PRODUCT NAME: PLAVIX-CLOPIDOGREL; REG. NO/DATE: EU/1/98/069/001 19980715
00722 Netherlands ➤ Try a Free Trial PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720
2014 00037 Denmark ➤ Try a Free Trial PRODUCT NAME: ET KOMBINATIONSPRODUKT AF DAPAGLIFLOZIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER DAPAGLIFLOZINPROPANDIOLMONOHYDRAT OG METFORMIN ELLER SALTE DERAF, HERUNDER METFORMINHYDROCHLORID; REG. NO/DATE: EU/1/13/900 20140116
00028 Netherlands ➤ Try a Free Trial PRODUCT NAME: LEVETIRACETAM; REGISTRATION NO/DATE: EU/1/00/146/001 - EU/1/00/146/026 20000929
C/GB97/018 United Kingdom ➤ Try a Free Trial PRODUCT NAME: CANDESARTAN CILEXETIL OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; REGISTERED: UK PL0017/0383 19970429; UK PL0017/0384 19970429; UK PL0017/0385 19970429; UK PL0017/0391 19970429; UK PL15561/0003 19970429; UK PL15661/0001 19970429; UK PL15661/0002 19970429; UK PL15661/0004 19970429
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Chubb
Daiichi Sankyo
Accenture
AstraZeneca
Deloitte
Argus Health
Federal Trade Commission
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.